Psychotropic Medicines
Cross-source consensus on Psychotropic Medicines from 1 sources and 4 claims.
1 sources · 4 claims
Risks & contraindications
Comparisons
Evidence quality
Highlighted claims
- The programme responds to concerns about misuse, overuse, and off-label use of psychotropic medicines for behaviours of concern in people with intellectual and developmental disabilities. — ASPIRE-Med project: a study protocol on an Australian psychotropic medicines training programme for disability support workers
- International guidance recommends trying psychosocial and behavioural interventions before using psychotropic medicines for behaviours of concern. — ASPIRE-Med project: a study protocol on an Australian psychotropic medicines training programme for disability support workers
- The 2023 Australian Royal Commission found substantial evidence of over-prescribing and chemical restraint use in this population. — ASPIRE-Med project: a study protocol on an Australian psychotropic medicines training programme for disability support workers
- Psychotropic medicines can cause adverse effects, including serious effects that may contribute to early death. — ASPIRE-Med project: a study protocol on an Australian psychotropic medicines training programme for disability support workers